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Abstract
All Yersinia species target and bind to phagocytic cells, but uptake and destruction of bacteria are prevented by injection of
anti-phagocytic Yop proteins into the host cell. Here we provide evidence that CD8
+ T cells, which canonically eliminate
intracellular pathogens, are important for restricting Yersinia, even though bacteria are primarily found in an extracellular
locale during the course of disease. In a model of infection with attenuated Y. pseudotuberculosis, mice deficient for CD8
+ T
cells were more susceptible to infection than immunocompetent mice. Although exposure to attenuated Y.
pseudotuberculosis generated TH1-type antibody responses and conferred protection against challenge with fully virulent
bacteria, depletion of CD8
+ T cells during challenge severely compromised protective immunity. Strikingly, mice lacking the
T cell effector molecule perforin also succumbed to Y. pseudotuberculosis infection. Given that the function of perforin is to
kill antigen-presenting cells, we reasoned that cell death marks bacteria-associated host cells for internalization by
neighboring phagocytes, thus allowing ingestion and clearance of the attached bacteria. Supportive of this model, cytolytic
T cell killing of Y. pseudotuberculosis–associated host cells results in engulfment by neighboring phagocytes of both bacteria
and target cells, bypassing anti-phagocytosis. Our findings are consistent with a novel function for cell-mediated immune
responses protecting against extracellular pathogens like Yersinia: perforin and CD8
+ T cells are critical for hosts to
overcome the anti-phagocytic action of Yops.
Citation: Bergman MA, Loomis WP, Mecsas J, Starnbach MN, Isberg RR (2009) CD8
+ T Cells Restrict Yersinia pseudotuberculosis Infection: Bypass of Anti-
Phagocytosis by Targeting Antigen-Presenting Cells. PLoS Pathog 5(9): e1000573. doi:10.1371/journal.ppat.1000573
Editor: C. Erec Stebbins, The Rockefeller University, United States of America
Received January 16, 2009; Accepted August 10, 2009; Published September 4, 2009
Copyright:  2009 Bergman et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Howard Hughes Medical Institute, awards R37AI23538 (R.I.), AI056068 (J.M.), AI055962 and AI39558 (W.L. and M.S.)
from the National Institute of Allergy and Infectious Disease, American Cancer Society postdoctoral fellowship grant PF0325701MBC (M.B.) and National Institute
of Diabetes and Digestive and Kidney Diseases (NIDDK) program center grant P30DK34928. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ralph.isberg@tufts.edu
¤ Current address: Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America
Introduction
Three Yersinia species cause disease in humans: Y. pestis, Y.
pseudotuberculosis, and Y. enterocolitica [1]. Plague results from Y. pestis,
introduced via fleabite or contaminated aerosols, and manifests in
bubonic, septicemia, and pneumonic forms [2]. Oral ingestion of
Y. pseudotuberculosis or Y. enterocolitica from contaminated food or
water causes yersiniosis, which is typified by gastroenteritis and
mesenteric lymphadenitis, with occasional arthritic sequelae [3].
Despite differing infection routes and disease manifestations, all
Yersinia species demonstrate a tropism for lymphoid tissue and an
ability to disseminate from initial infection sites to colonize
systemic organ sites, where unchecked bacterial replication causes
fatal disease [4,5].
Yersinia express a battery of virulence factors to cause disease in
susceptible human and animal hosts. Enteric Yersinia express
several adhesins in order to bind to host cells and penetrate the
intestinal epithelium [6–12]. Y. pestis expresses a different subset of
adhesins to mediate host cell binding and facilitate dissemination
[13–16]. Adhesion of Yersinia to host cells is required for delivery of
Yersinia outer proteins (Yops) into the host cell cytoplasm via a
specialized secretion machine called the type III secretion system
(T3SS) [17]. Yersinia express six Yops; YopE, H, J (also called P),
M, O, and T [18], which perturb eukaryotic cell signaling
pathways, resulting in inhibition of phagocytosis, alteration of
cytokine production [18], and direct intoxication of phagocytes
during animal infections [19]. The importance of Yop-induced
inhibition of phagocytosis is supported by two lines of evidence:
1) Yop-deficient Yersinia species fail to cause disease [20–23], and
2) histological studies demonstrate that Yersinia localize to the
extracellular space of infected tissues [24–26]. This anti-phagocy-
tosis phenotype can be easily reproduced during Yersinia
association with tissue culture cells [27]. Delivery of Yops requires
intimate attachment, as bacteria lacking defined adhesion factors
are defective for Yop translocation [28]. Thus, the combined
action of adhesins and Yops synergize to localize Yersinia in a
discrete niche as extracellularly attached bacteria [29].
T cells survey for pathogens by virtue of T cell receptor
recognition of antigen bound to major histocompatibility complex
(MHC) on the surface of infected host cells. CD4
+ T cells
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presented by MHC II. CD8
+ T cells respond to cytoplasmic
antigens, with processed peptide complexed with MHC I [30]. A
requirement for cell-mediated immune responses against Yersinia
has been dismissed, given that Yersinia is an extracellular pathogen
and that immune serum is sufficient to protect mice against
virulent challenge [31,32]. The observed intracellular localization
of Yop proteins [33], however, has suggested that T cells may
respond to Yop-derived antigens. Moreover, there is evidence
showing that CD4
+ and CD8
+ T cells are required for protection
against Y. pestis and Y. enterocolitica in animal models of infection
[34–36]. The mechanism of T cell restriction of Yersinia is
unknown. Studies have suggested that IFNc secretion by T cells is
important [37], presumably by activating antimicrobial functions
in phagocytes [38]. This suggestion explains the function of
Yersinia-specific CD4
+ T cells, but may only partially account for
the mechanism of CD8
+ T cell restriction of the bacteria. CD8
+,
or cytolytic T cells (CTLs), can eliminate pathogen-harboring cells
by inducing death of target cells, which removes a niche for
intracellular pathogen replication [39]. The possibility that CTL-
induced host cell death could interfere with disease by extracellular
pathogens has not been addressed.
We hypothesized that the intimate association of Y. pseudotuber-
culosis with host cells may allow recognition by CD8
+ T cells and
result in restriction of disease. To test this hypothesis, a model of
murine infection with live attenuated Y. pseudotuberculosis was used
to determine the disease susceptibility of mice defective in specific
arms of cell-mediated immunity. CD8
+ T cells and perforin-
dependent cytolysis were critical for protecting against Y.
pseudotuberculosis. CD8
+ T cell recognition of target cells bypasses
anti-phagocytosis by Y. pseudotuberculosis, which is consistent with
the model that restriction results from CTLs marking host cells
and attached bacteria for phagocytic removal.
Results
Attenuated Y. pseudotuberculosis Colonization of Mice
Induces Protective Immunity
As naı ¨ve mice rapidly succumb to disease caused by virulent Y.
pseudotuberculosis [4,5], we instead used the attenuated ksgA
2 strain
[40] to investigate how CD8
+ T cells protect against Y.
pseudotuberculosis. The absence of KsgA results in a lowered
replication rate in culture relative to wild-type bacteria [41] due
to the loss of dimethylation of 16S rRNA [42]. To confirm that Y.
pseudotuberculosis ksgA
2 attenuates virulence in animal hosts,
C57BL/6 mice were orally inoculated with 5610
8 colony-forming
units (CFU) of the ksgA
2 strain and bacterial burden was followed
in target organs over time. Mice inoculated with the mutant
showed detectable levels of bacteria in all organs examined for the
first ten days post-inoculation, after which the levels dropped
below the limit of detection (Figure 1), and most animals survived
(data not shown). The small intestine and Peyer’s patches were
colonized at higher levels than the mesenteric lymph nodes, spleen
or liver. In contrast, C57BL/6 mice orally inoculated at the same
dose with the virulent parental strain supported increasingly
greater levels of bacteria until eventually succumbing to disease
eight days post-inoculation [43]. The ksgA
2 strain was attenuated
following a non-intestinal route of inoculation, as well. After
intravenous delivery, ksgA
2 bacteria colonized the spleen and liver
at lower levels than the parental strain at day 5 post-inoculation
and at levels approaching a known avirulent strain lacking the
ability to translocate Yops into cells (yopB
2 [44]) (Figure S1).
Prior exposure to attenuated pathogens can generate protective
immunity against subsequent challenge with fully virulent
organisms [45–47]. Previous oral inoculation with Y. pseudotuber-
culosis ksgA
2 bacteria conferred protection against the virulent
YPIII pIB1 comparable to a published vaccine strain that
overproduces Dam methylase [48] (91% versus 100% survival,
Table 1), whereas all naı ¨ve mice succumbed to challenge (0%
survival). Moreover, orally immunized mice were protected
against challenge with intravenously administered virulent bacteria
(100%), indicating that the specificity of the response was not
restricted to antigens expressed by bacteria at the initial
immunization site. Immunization with ksgA
2 bacteria, which is
derived from the YPIII pIB1 background [40], also protected
against oral challenge with strain IP2666, another virulent Y.
pseudotuberculosis strain [49] capable of causing fatal disease in naı ¨ve
mice (data not shown). These results demonstrate that exposure to
attenuated Y. pseudotuberculosis ksgA
2 bacteria generates immune
responses sufficient to protect against virulent disease.
Attenuated Y. pseudotuberculosis Infection Induces
Humoral and Cell-Mediated Immune Responses
Correlates of protective immunity include the presence of
antigen-specific antibodies and T cell responses following
antigenic exposure. The total antibody response to Y. pseudotuber-
culosis was significantly higher in sera from ksgA
2-immunized
mice than from naı ¨ve mice, with a 28 fold greater median value
for the half-maximal antibody titer in immune animals
(Figure 2A, P=0.0012). Antibody isotyping revealed that
ksgA
2-immune mice possessed anti-Yersinia IgA antibodies, as
would be predicted from a mucosal immunization regimen
(Figure 2B), as well as robust IgG2a and detectable IgG1
responses (data not shown). Y. pseudotuberculosis-immune mice
displayed a significantly more IgG2a than IgG1 isotypic
antibodies (Figure 2C, median ratios 5.9 and 0.4, respectively,
P=0.0004), indicative of a TH1-type T cell response [50].
Correspondingly, CD4
+ and CD8
+ T cells were activated at day
seven post-inoculation with the ksgA
2 mutant, as determined by
an increase in CD69
+ lymphocytes in mesenteric lymph nodes as
compared to naı ¨ve animals, although activated lymphocytes were
not detected in the ksgA
2-colonized Peyer’s patches at this time
point (Figure 2D, E). The increase in the percentage of
activated lymphocytes was due to an increase in the number of
activated cells relative to the total number of lymphocytes. The
Author Summary
Pathogenic Yersinia are bacteria that cause diverse
diseases such as gastroenteritis and plague. Yersinia binds
to specialized immune cells called macrophages, which
attempt to engulf and destroy the bacteria. The bacteria
resist destruction by injecting proteins called Yops into
macrophages, which stops the engulfment process.
Yersinia thus survives as attached but extracellular bacteria
to cause disease. Yersinia disease can be prevented by
immunization. In this study, we identified one mechanism
of protective immunity—that host cells called CD8
+ T
lymphocytes are important to restrict Yersinia infection.
This observation is unusual because CD8
+ T cells generally
protect against intracellular pathogens: T cells destroy the
host cell harboring the pathogen, thus preventing the
pathogen’s replication. We present data consistent with
the model that CD8
+ T cells can also restrict extracellular
bacteria by showing that T cells target host cells with
extracellularly attached Yersinia, thus allowing the host
cells and associated bacteria to be engulfed and removed
by neighboring macrophages.
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+ lymphocytes was similar between animals
regardless of the presence of bacteria (data not shown), but the
number of activated CD8
+ lymphocytes was higher in animals
harboring bacteria. Taken together, these results indicate that
both humoral and cell-mediated immune responses are stimulat-
ed in mice exposed to attenuated Y. pseudotuberculosis.
CD8
+ T Cells Are Required to Protect Against Y.
pseudotuberculosis Infection
The observation that exposure to attenuated Y. pseudotuberculosis
activates CD8
+ T cells was intriguing, given that CD8
+ T cells are
thought to target intracellular pathogens, while Yersinia species are
generally regarded to be extracellular pathogens. To investigate if
CD8
+ T cells restrict Y. pseudotuberculosis colonization, mice
deficient for b2-microglobulin (B2m
2/2), which lack MHC Class
I and thus lack CD8
+ T cells [51,52], were inoculated with the
ksgA
2 mutant. At eight days post-inoculation, the ksgA
2 mutant
colonized the Peyer’s patches (Figure 3A) and small intestine
Figure 1. Y. pseudotuberculosis ksgA
2 is Attenuated in a Murine Model of Infection. C57BL/6 mice were orally inoculated with 5610
8 CFU of
mutant ksgA
2 strain and mice sacrificed at days 3, 7, 11 and 14 post-inoculation. The number of bacteria in the small intestine (A), Peyer’s patches (B),
mesenteric lymph nodes (C), spleen (D) and liver (E) was determined by plate assay and normalized to gram tissue weight. Open symbols indicate
that the bacterial numbers were below the limit of detection. Each symbol indicates one mouse.
doi:10.1371/journal.ppat.1000573.g001
Table 1. Immunization with the ksgA
2 Mutant Protects
Against Challenge by Virulent Y. pseudotuberculosis.
Immune Status
a % Survival (N/N)
c
naı ¨ve 0 (0/9)
Dam
OP 100 (4/4)
ksgA
2 91 (11/12)
ksgA
2b 100 (4/4)
aMice were orally immunized with the indicated strain and 60–90 days post-
immunization were orally challenged with 2610
9 CFU virulent Y.
pseudotuberculosis strain YPIII pIB1.
bImmune mice were intravenously challenged with 5610
2 virulent Y.
pseudotuberculosis.
cFailure to survive was scored if mice succumbed to challenge or were
moribund.
doi:10.1371/journal.ppat.1000573.t001
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2/2 mice at similar levels,
indicating that Y. pseudotuberculosis replicates in the gastrointestinal
tract independently of b2-microglobulin-dependent mechanisms.
However, the mesenteric lymph nodes, spleen and liver of B2m
2/2
mice were colonized at significantly higher levels with attenuated
bacteria as compared to C57BL/6 mice, demonstrating that
B2m
2/2 mice are highly susceptible to the ksgA
2 mutant
(Figure 3B, C, D). In addition to lacking cell-mediated immune
functions, B2m
2/2 mice have an additional phenotype of iron
overload, similar to human hemochromatosis [53]. Given that
hemochromatosis is a risk factor for extraintestinal infection by
enteric Yersinia in humans [54], we evaluated the colonization of Y.
pseudotuberculosis in B2m
2/2 mice following parenteral inoculation.
This allows the infection route to bypass the intestine and avoid
hemochromatosis-dependent enhancement of extraintestinal dis-
semination. At nine to ten days post-inoculation, intravenously
delivered ksgA
2 mutant bacteria colonized the spleen and liver of
B2m
2/2 knockout animals at significantly higher levels than
observed in C57BL/6 mice (Figure 3E, F), indicating that the
enhanced susceptibility of the knockout mice to Y. pseudotuberculosis
cannot entirely be attributed to increased extraintestinal dissem-
ination. Therefore CD8
+ T cells, or cells and/or functions
requiring b2-microglobulin, are necessary to eliminate attenuated
Y. pseudotuberculosis.
To more specifically isolate the role of CD8
+ T cells in
controlling colonization with attenuated Y. pseudotuberculosis,
C57BL/6 mice were depleted of CD8
+ T cells [55] (Materials
and Methods) and inoculated with ksgA
2 bacteria. Bacteria were
delivered directly to the systemic organs by intravenous injection,
to ensure that the mutant was introduced into organ sites that have
a high likelihood of depletion. This was effective in reducing the
scatter found in CFU isolated from systemic tissue sites after oral
inoculation, presumably resulting from bottlenecking associated
with extraintestinal dissemination [43]. At 14 days post-inocula-
tion, mice depleted of CD8
+ T cells displayed a 1.2 and 1.4 log
increase in CFU in the spleen and liver, respectively (Figure 4A,
B), as compared to mock-depleted mice, although differences were
only statistically significant in the liver (P=0.008). More striking
was the frequency of colonization: while some of the mock-
depleted animals showed no colonization (33%, 5 of 15 mice), all
of the CD8-depleted mice contained ksgA
2 bacteria in either the
liver or spleen (100%, 12 of 12 mice). CD8
2/2 mice [56] also
demonstrated increased susceptibility to systemic colonization with
ksgA
2 bacteria at day 14 post-inoculation (median value of 10
4
versus 10
2 CFU/gram tissue in livers of CD8
2/2 as compared to
C57BL/6 mice, P=0.02).
Although these experiments addressed the requirement for
CD8
+ T cells during colonization with attenuated Y. pseudotuber-
culosis in naı ¨ve animals, that is, those not previously exposed to the
bacterium, the observed phenotype of increased colonization in
CD8-deficient mice was detected only at 14 days post-inoculation,
at a time when adaptive immune mechanism are likely involved in
protection. To demonstrate that the requirement for CD8
+ T cells
is associated with enhanced adaptive immunity to Y. pseudotuber-
culosis, and to show that CD8
+ T cell responses are effective against
fully virulent bacteria, mice orally immunized with the ksgA
2
mutant were depleted of CD8
+ T cells prior to and following
intravenous challenge with wild-type Y. pseudotuberculosis. 100% of
depleted mice succumbed to virulent bacteria within one week
post-inoculation, whereas all mock-depleted immune mice sur-
vived challenge (Figure 4C); the two survival curves were
significantly different (P=0.003). These results demonstrate that
effective protective immunity to Y. pseudotuberculosis requires the
presence of CD8
+ T cells.
Figure 2. Colonization by ksgA
2 Induces TH1-type Antibodies and Activates T Cell Responses. Naı ¨ve mice or mice orally inoculated with
ksgA
2 bacteria 60 days prior were sacrificed, sera harvested and assayed for Y. pseudotuberculosis-specific antibodies. Shown are the half-maximal
titer of ‘‘total’’ serum antibodies (combined IgM, IgA, IgD, IgG) (A), and the concentrations of IgA (B), and IgG1 and IgG2a serum antibodies (C) specific
to total Yersinia antigen. 7 days post-oral inoculation, the percentage of CD69
+ CD4
+ (D) or CD69
+ CD8
+ (E) T cells present in the Peyer’s patches (PP)
and mesenteric lymph nodes (MLN) was determined. Each symbol represents one animal: filled symbols are animals exposed to Y. pseudotuberculosis
and open symbols are naı ¨ve animals.
doi:10.1371/journal.ppat.1000573.g002
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Infection
CD8
+ T cells mediate protective immune responses via
secreting cytokines or by directly killing target cells and removing
a niche for pathogen intracellular replication. Cytolytic T cells
(CTLs) can kill target cells via localized secretion of perforin,
which inserts into target cell membranes and facilitates entry of
other secreted molecules involved in target cell killing such as
granzymes and granulysins, interrupting growth of intracellular
pathogens in target cells [57]. To address the requirement for
perforin in protecting against Y. pseudotuberculosis replication,
perforin-deficient (PKO) [58] and -sufficient mice were intrave-
nously inoculated with the ksgA
2 mutant and bacterial coloniza-
tion in systemic organ sites was examined. PKO mice were highly
susceptible to growth of attenuated Y. pseudotuberculosis, with
increased bacterial burden as compared to C57BL/6 mice in
both spleen (1.4 log CFU median increase, P=0.0006) and liver
(1.5 log CFU median increase, P=0.0003) at day 14–15 post-
inoculation (Figure 5A, B). These results demonstrate that
perforin function is required to eliminate attenuated Y. pseudotu-
berculosis, and suggest that CD8
+ T cells limit bacterial replication
by perforin-dependent mechanisms. To determine if perforin plays
a role in protective immune responses to Y. pseudotuberculosis,w e
repeated immunizations of perforin-deficient animals and C57BL/
6 mice, extending the time post-inoculation beyond 14 days.
Perforin deficiency impaired the immune response even to the
attenuated strain, as 3 of the 9 knockout animals succumbed to
immunizing strain by 3 weeks post-inoculation, as compared to 1
Figure 3. b2-Microglobulin-Deficient Mice Are Highly Susceptible to Attenuated Y. pseudotuberculosis. C57BL/6 (black circles) or B2m
2/2
(grey circles) mice were orally inoculated with 5610
8 CFU attenuated ksgA
2 bacteria, sacrificed at day 8–10 post-inoculation and bacterial burden
assayed in Peyer’s patches (A), mesenteric lymph nodes (B), spleen (C), and liver (D). Open symbols indicate values below the limit of detection for
that organ. Alternatively, C57BL/6 mice or B2m
2/2 mice were intravenously inoculated with 2610
2 CFU ksgA
2 bacteria, sacrificed at day 10 post-
inoculation and bacteria burden in the spleen (E) and liver (F) determined. Each symbol represents one animal, lines are median values. Data shown is
pooled from two-three separate experiments.
doi:10.1371/journal.ppat.1000573.g003
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2 immuniza-
tion were then subjected to challenge with virulent Y. pseudotu-
berculosis. Mice intravenously immunized with 10
2 CFU ksgA
2 60
days prior were challenged via the same route with 10
3 CFU YPIII
pIB1, a dose that is virulent for naı ¨ve C57BL/6 animals (data not
shown). At seven days post-challenge, perforin-deficient Y.
pseudotuberculosis-immune mice demonstrated higher bacterial
burden in spleens and livers than control immune C57BL/6 mice
(Figure 5C, D); knockout animals with detectable colonization
had significantly higher median CFU values: in the spleen, 5.67
versus 4.39 for perforin-deficient versus C57BL/6 (p-value=0.02);
in the liver, 3.93 versus 3.08 for perforin-deficient versus C57BL/6
mice, p-value=0.01). Thus, perforin-deficient animals immunized
with Y. pseudotuberculosis were more susceptible to challenge with
fully virulent bacteria than control C57BL/6 mice. The increased
susceptibility of perforin-deficient mice both to primary infection
with attenuated Y. pseudotuberculosis and challenge infection with
virulent bacteria indicates that perforin is required during the
initial and memory phases of the immune response. During
primary exposure to attenuated Y. pseudotuberculosis, the enhanced
susceptibility in perforin-deficient mice as compared to mice
lacking CD8
+ T cells could result from the absence of perforin in
other cell types such as natural killer (NK) and NK T cells [39].
Even so, there is no established model for how any of these cells
could clear extracellular pathogens in a perforin-dependent
fashion.
Y. pseudotuberculosis Maintains an Extracellular Locale in
the Absence of CD8
+ T cells or Perforin
Cell-mediated immune responses are thought to eliminate
intracellular pathogens. While members of the Yersinia genus are
generally considered to be extracellular pathogens, Y. pestis and Y.
pseudotuberculosis have been shown to replicate inside cultured
macrophages if the bacteria express low levels of Yops [59,60]. This
raisesthepossibilitythatareservoirofintracellularbacteriamayseed
the extracellularbacterial population, allowing Yersinia-specificCTLs
to restrict Yersinia colonization by targeting phagocytes with
intracellular bacteria. This model predicts that mice with impaired
CTL function have a larger fraction of intracellular Yersinia than do
wild type mice. To test this hypothesis, we determined the levels of
intracellular Y. pseudotuberculosis in mice lacking perforin, b2-
microglobulin, or CD8
+ T cells, using a previously described ‘‘ex
vivo’’ gentamicin protection assay ([61] see Materials and Methods).
Mice were intravenously inoculated with Y. pseudotuberculosis, and
at the indicated time points post-inoculation, spleen cell suspen-
sions were treated with gentamicin (Figure 6). As a positive
control for intracellular bacteria, animals were also inoculated with
S. typhimurium [61]. Spleen cell suspensions from Y. pseudotubercu-
losis-inoculated C57BL/6 harbored lower numbers of gentamicin-
protected bacteria at 3–4 days post-inoculation as compared to
animals inoculated with S. typhimurium 5 days prior (Figure 6A).
The phoP
2 YPIII pIB1 strain displayed reduced numbers of
intracellular bacteria in spleen suspensions (Figure 6A) and in
Figure 4. CD8
+ T cells are Required to Protect Against Y. pseudotuberculosis. Naı ¨ve mice were given phosphate-buffered saline (PBS, black
circles) or CD8-depleting antibody 2.43 (a-CD8, grey circles) prior and subsequent to intravenous inoculation with 10
2 CFU ksgA
2 bacteria, sacrificed
at day 14 post-inoculation and CFU enumerated in the spleen (A) and liver (B). Open symbols indicate the limit of detection for that organ, each
symbol represents one mouse, and lines are median values. Data shown is pooled from three separate experiments. (C) To examine protection in
immune animals, at 60 days post-oral ksgA
2 immunization, mice received PBS (black circles) or CD8-depleting antibody 2.43 (a-CD8, grey circles) prior
and subsequent to intravenous inoculation with 10
4 CFU virulent YPIII pIB1 (ksgA
+) bacteria. Morbidity and mortality was followed for 14 days post-
challenge and % survival shown by Kaplan-Meier plots. Data is representative of two experiments.
doi:10.1371/journal.ppat.1000573.g004
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+ strain
(IP2666), confirming prior observations of the importance of PhoP
for intracellular survival replication [62,63].
Using the gentamicin protection assay, we then examined the
yields of intracellular bacteria in PKO, B2m
2/2 and control
C57BL/6 mice at 10–14 days post-inoculation with the YPIII
ksgA
2 strain, when bacterial burdens were highest in the spleen
(Figures 3, 5). The ksgA
2 mutant displayed very low yields of
gentamicin protection in spleen cell suspensions from C57BL/6
mice (Figure 6B). The protection efficiencies of bacteria isolated
from spleens of animals lacking either b2-microglobulin or
perforin were similar to those obtained from control C57BL/6
Figure 5. Perforin Is Required to Restrict Y. pseudotuberculosis Colonization. C57BL/6 (black circles) or perforin-deficient animals (PKO, grey
circles) mice were intravenously inoculated with 10
2 attenuated ksgA
2 bacteria and mice sacrificed at day 14–15 post-inoculation to assay bacterial
burden in spleen (A), and liver (B). To examine protection in immune animals, at 60 days post-intravenous ksgA
2 immunization, mice were
intravenously challenged with 10
3 CFU virulent YPIII pIB1 (ksgA
+) bacteria and bacterial burden assayed in the spleen (C) and liver (D) at day 7 post-
challenge. Open symbols indicate the limit of detection for that organ. Each symbol represents one mouse, lines are median values. Data shown is
pooled from two-three separate experiments.
doi:10.1371/journal.ppat.1000573.g005
Figure 6. Y. pseudotuberculosis Localizes Extracellularly in the Spleen Despite the Absence of Cytolytic T cell Control. Single cell
suspensions of spleens from animals exposed to bacteria were assayed for the presence of intracellular bacteria using a gentamicin protection assay –
spleen cells were assayed for CFU without and with gentamicin treatment, and % gentamicin-protected bacteria calculated (see Materials and
Methods). (A) C57BL/6 mice were intravenously inoculated with Y. pseudotuberculosis strain YPIII pIB1 or IP26666 (2610
3 CFU), or S. typhimurium strain
SL1344 (5610
2 CFU) and sacrificed 3–5 days post-inoculation. (B) C57BL/6, PKO and B2m
2/2 mice were intravenously inoculated with 10
2 CFU ksgA
2
bacteria and sacrificed after 10–14 days post-inoculation. (C) Naı ¨ve or Y. pseudotuberculosis-immune C57BL/6 mice treated with PBS or CD8-depleting
antibody 2.43 (see Figure 4 legend) were challenged with 10
4 virulent YPIII pIB1 and sacrificed day 4 post-challenge. Values show means and S.E.M.
for several experiments; number of animals used for each condition is listed below each experimental condition.
doi:10.1371/journal.ppat.1000573.g006
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2 immunized
mice were depleted of CD8
+ T cells during challenge with wild
type Y. pseudotuberculosis, the fraction of gentamicin-protected
bacteria in spleen cells was no higher than in mock-depleted mice
or age-matched naı ¨ve mice at day 4 post-challenge (Figure 6C).
These observations indicate that mice lacking b2 microglobulin,
perforin, or CD8
+ T cells do not show increased susceptibility to Y.
pseudotuberculosis as a result of an increased burden of intracellular
bacteria, but are consistent with a mechanism of cell-mediated
immune restriction against Y. pseudotuberculosis that functions to
eliminate extracellular bacteria.
CTLs Target Y. pseudotuberculosis-Associated Antigen-
Presenting Cells But Do Not Alter Bacterial Localization
We next considered the possibility that the predominant locale for
Yersinia, extracellular but attached tohostcells, allowscytolytic CD8
+
T cells (CTLs) to directly inhibit bacterial replication, by instructing
antigen-presenting cells (APCs)to internalize or kill surface-bound Y.
pseudotuberculosis. To test this possibility, we established a cell culture
system that recapitulates CD8
+ T cell cytolysis of APCs harboring Y.
pseudotuberculosis. We used a surrogate CTL antigen, as natural
bacterial antigens recognized by CD8
+ T cells from Yersinia-immune
mice have not been identified. Primary macrophages, a target of
Yersiniainvivo[19],were usedas APCsand incubatedwith CrpA63–71
peptide, which is recognized by CTLs derived from Chlamydia-
immune mice [64]. Peptide-presenting macrophages were effectively
lysed by a CrpA63–71-specific CTL line, regardless of the presence of
bacteria (Figure 7A), indicating that Y. pseudotuberculosis did not
impair CTL killing of APCs. In contrast, bacteria-associated
macrophages lacking peptide showed high viability following T cell
exposure, similar to the macrophages exposed to media only. The
degree of CTL-induced macrophage death was comparable to that
observed with a standard antigen-presenting cell line (thymic
carcinoma cell line EL4, Figure 7A), confirming that macrophages
are targeted equally as well as conventional APCs. These results
demonstrate that antigen-specific CTLs kill cultured APCs harbor-
ing surface-attached Y. pseudotuberculosis.
We then examined the consequence of CD8
+ T cell targeting
upon Y. pseudotuberculosis internalization by the target host cell.
APCs were incubated with bacteria, pulsed with peptide and
exposed to CTLs, and bacterial internalization by the APCs was
assessed using an immunofluorescence protection assay on fixed
cells (see Methods). Control incubations of APCs with wild-type Y.
pseudotuberculosis or mutant bacteria deficient for translocation of
anti-phagocytosis proteins (T3SS
+ or T3SS
2, respectively) dem-
onstrated that wild-type bacteria localize as extracellularly-
attached bacteria (Figure 7B, panels 1–5, pink bacteria), while
T3SS
2 bacteria were found intracellularly (Figure 7B, panels 6–
10, blue bacteria), as has been previously observed [65]. CTL
exposure to APCs with associated Y. pseudotuberculosis failed to alter
the localization of wild-type bacteria, regardless of whether peptide
was added (Figure 7B, panels 11–15, no peptide; 16–20, plus
peptide, Figure 7C). Altering the CTL exposure time or the
CTL-to-APC ratio did not impact bacterial localization, nor did
CTL targeting of APCs cause any decrease in viability of surface-
attached bacteria (data not shown). Therefore, CTL killing of Y.
pseudotuberculosis-associated APCs is insufficient to directly influence
bacterial uptake or viability in this cell culture system.
CTLs Indirectly Restrict Y. pseudotuberculosis by Marking
APCs with Attached Bacteria for Phagocytic Removal
We next tested if CTLs could eliminate Y. pseudotuberculosis by
targeting APCs and attached bacteria for phagocytosis by
activated macrophages. We first tested whether recognition of
dead cells by activated phagocytes could be readily demonstrated.
Media-treated (viable) GFP
+ cells resisted engulfment, whereas
gliotoxin-treated (apoptotic) GFP
+ cells were efficiently internal-
ized by GFP
2 IFNc-activated macrophages (Figure 8A, panels 1–
3 media, panels 4–6 gliotoxin; Figure 8B). Thus, this assay could
be used to analyze the role of CTLs in promoting engulfment by
activated phagocytes. To this end, GFP
+ APCs with attached
extracellular bacteria were exposed to CTLs, incubated with
nonfluorescent activated macrophages, and uptake of apoptotic
corpses and bacteria was quantified.
Internalization of bacteria and GFP
+ APCs by the activated
macrophages required CTL targeting of the APCs. In the absence
of CTLs, Y. pseudotuberculosis exposure was insufficient to mark
GFP
+ APCs for engulfment by neighboring activated macrophages
(Figure 8A, panels 7–9, Figure 8B). Similarly, APCs exposed to
both bacteria and CTLs in the absence of peptide resisted
engulfment (Figure 8A, panels 10–12), as only 9.2+1.8% of GFP
+
APCs harboring bacteria were engulfed by activated macrophages
if there was no peptide present (Figure 8B). However, GFP
+
APCs harboring Y. pseudotuberculosis were phagocytosed at a high
frequency, with 55.663.2% of cells internalized, if they were
challenged with peptide and targeted by CTLs prior to exposure
to the activated macrophages (Figure 8A, panels 13–15;
Figure 8B). As CTL targeting enhanced engulfment of GFP
+
APCs, we then determined if the bacteria associated with APCs
were altered for localization, using the previously described
antibody protection assay. CTL targeting of GFP
+ APCs
significantly enhanced bacterial internalization by activated
macrophages (Figure 8A, panels 13–15, Figure 8C, third
column), as compared to the absence of targeting (Figure 8A,
panels 10–12; Figure 8C, second column). Phagocytosis of APC-
associated Y. pseudotuberculosis after CTL targeting (Figure 8C,
third column) was comparable to that observed with bacteria
lacking the TTSS (Figure 8D, second column). Eliminating the
possibility that bystander phagocytosis was limited to those APCs
already harboring intracellular bacteria, the non-phagocytosed
APCs displayed the same proportions of intracellular bacteria
regardless of CTL targeting (Figure S3). Thus, CTL killing of Y.
pseudotuberculosis-associated APCs defeats the anti-phagocytic activ-
ities of Yops, and allows bystander phagocytes to co-engulf
bacteria associated with dead host cells.
Discussion
We show here that CD8
+ T cells and perforin are involved in
protection against Yersinia pseudotuberculosis. We also present
evidence that CD8
+ T cells target antigen-presenting cells with
attached bacteria for bystander phagocytosis. These findings are
significant because CD8
+ T cells and perforin targeting of APCs
are thought to clear intracellular pathogens, while Yersinia species
are generally considered to be extracellular [18]. Yersinia express
proteins that facilitate tight binding to phagocytes, then inject anti-
phagocytic Yops to maintain an extracellular, but attached, locale.
We propose a model for how CTLs counteract bacteria in this
niche: CD8
+ T cells kill Yersinia-associated host cells, thus allowing
apoptotic cells to be ingested by neighboring host cells and
attached bacteria to be co-engulfed (Figure 8D). This uptake
could be a death knell for the bacteria, as it essentially trumps the
anti-phagocytic Yops.
The observation that CD8
+ T cells were activated by attenuated
Y. pseudotuberculosis bacteria (Figure 2) suggested that these host cells
might protect against Yersinia. Indeed, mice devoid of CD8
+ Tc e l l s
due to the absence of b2-microglobulin (Figure 3) were more
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PLoS Pathogens | www.plospathogens.org 8 September 2009 | Volume 5 | Issue 9 | e1000573Figure 7. CTL Targeting of Y. pseudotuberculosis-Associated APCs Does Not Induce Bacterial Uptake by APCs. (A) Bone-marrow derived
macrophages were pulsed with CrpA63–71 peptide, infected with Y. pseudotuberculosis and exposed to CrpA63–71-specific CTLs at a ratio of 10:1
CTL:APC for four hours, after which culture supernatants were evaluated for the presence of the cytoplasmic enzyme lactate dehydrogenase (LDH).
The EL4 thymoma cells were used as control antigen-presenting cells. Released LDH was normalized to the maximal amount of released LDH and %
cytotoxicity calculated (see Methods). Shown are the mean and standard error of the mean (SEM) for triplicate samples. (B) Macrophages were treated
with peptide and Y. pseudotuberculosis, exposed to CTLs at a ratio of 10:1 CTL:APC for 15 minutes, then cells were fixed and assayed for the presence
of extra- and intracellular bacteria by immunofluorescence microscopy. Representative images from one of four experiments are shown. Macrophage
treatment conditions: panels 1–5 T3SS
+ bacteria, panels 6–10 T3SS
2 bacteria, panels 11–15 T3SS
+ bacteria and CrpA-specific CTLs (no peptide), panels
16–20 T3SS
+ bacteria, CrpA63–71 peptide, and CrpA-specific CTLs. Panels from left to right show CD11b
+ macrophages (green), extracellular Yersinia
(red), internalized Yersinia (blue), merged images, and phase contrast. White bar represents 10 mm. (C) Quantification of intracellular bacteria: infected
macrophages were scored for intra- and extracellular bacteria and % intracellular Y. pseudotuberculosis calculated. Values shown are mean and SEM
for triplicate samples, and results are representative of three experiments.
doi:10.1371/journal.ppat.1000573.g007
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2 mutant, showing
increased bacterial burden in systemic organs regardless of
inoculation route. Interestingly, the B2m
2/2 mice did not display
increased bacterial colonization in the Peyer’s patches. Given our
prior observations that the bacterial populations responsible for
seeding systemic organs are derived from those bacteria present in
both the intestinal lumen and the Peyer’s patches [43], the increased
bacterialburdeninthesystemicorgansofB2m
2/2micesuggeststhat
the bottleneck of lumen dissemination has been widened in these
mice, such that bacterial populations present in systemic organs
should be more representative of those in the lumen, rather than the
Peyer’s patches. With regards to b2-microglobulin-dependent
immune responses, the enhanced susceptibility of B2m
2/2 mice to
diverse pathogens such as Trypanosoma cruzi, Listeria monocytogenes,
Chlamydia trachomatis, Mycobacterium tuberculosis and Klebsiella pneumoniae
[66–70] has been used to demonstrate a requirement for MHC I-
restricted T cells inprotection againstinfection. However,at least for
M. tuberculosis infection, the defect of B2m
2/2 mice may be due to
iron overload or hemochromatosis [71], as b2-microglobulin
associates with the MHC I family member HFE, which is involved
Figure 8. CTL Targeting Eliminates Both APCs and APC-Associated Y. pseudotuberculosis by Bystander Phagocytosis. (A)
Immunofluorescence images of GFP
+ APCs, pre-treated with media (panels 1–3), apoptosis-inducing gliotoxin (panels 4–6), Y. pseudotuberculosis
(panels 7–9), Y. pseudotuberculosis and CrpA-specific CTLs (panels 10–12), or Y. pseudotuberculosis, CrpA63–71 peptide and CrpA-specific CTLs (panels
13–15), then exposed to IFNc-activated macrophages. Panels from left to right show merged images of GFP
+ APCs (green) with extracellular Yersinia
(pink) and intracellular Yersinia (blue) (merge), phase contrast (phase), and phase contrast merged with GFP
+ APCs (GFP and phase). Arrowheads
indicate GFP
+ cells, arrows indicate bacteria. White bar represents 10 mm. (B) Quantification of GFP
+ host cells phagocytosed by activated
macrophages. GFP
+ cells were scored as unattached, attached or ingested by GFP
2 activated macrophages and % ingested GFP
+ host cells
calculated. (C) Quantification of localization of Y. pseudotuberculosis associated with GFP
+ APCs was performed similarly as described in Figure 7
legend: bacteria associated with GFP
+ APCs were scored for intra- and extracellular localization and % intracellular bacteria calculated. Results shown
are the mean and SEM of three triplicate samples per experiment; results are representative of three separate experiments. (D) Quantification of
intracellular bacteria in macrophages exposed to TTSS
+ or TTSS
2 Y. pseudotuberculosis (no CTLs or peptide present). (E) Model of CTL restriction of Y.
pseudotuberculosis: CTLs target bacteria-associated antigen-presenting cells for killing, apoptotic cells and attached bacteria are then engulfed and
removed by neighboring phagocytes.
doi:10.1371/journal.ppat.1000573.g008
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for disseminated infection by enteric Yersinia in humans [54], the
increased susceptibility of B2m
2/2 mice to oral inoculation with
attenuated Y. pseudotuberculosis (Figure 3) may only partially result
from the absence of CD8
+ T cells. We did observe that knockout
animals inoculated via a parental, i.e. non-oral, route also showed
increased bacterial burden in systemic tissues, indicating that the
enhanced susceptibility of the knockout mice cannot solely be
explained by enhanced intestinal dissemination. It is also possible
that the lack of natural killer T cells in B2m
2/2 mice [73] may
contribute to the increased susceptibility to attenuated Y. pseudotu-
berculosis in this model. To more precisely examine the requirement
for CD8
+ T cells in protecting against Y. pseudotuberculosis,w et e s t e d
additional mouse models of CD8 deficiency. The failure of CD8-
depleted naı ¨ve mice to resist colonization with attenuated Y.
pseudotuberculosis or CD8-depleted immune mice to survive virulent
challenge (Figure 4) demonstrates that CD8
+ cells are required for
protective anti-Y. pseudotuberculosis immune responses. Similar
observations have been made for Y. pestis, where CD8
+ T cells help
protect Y. pestis-immune mice from challenge [35,36].
The mechanisms used by T cells to protect hosts against
challenge with Yersinia are undefined, as tools to probe Yersinia-
specific T cell responses are lacking. Yop proteins are obvious
candidates for natural antigens recognized by T cells, by virtue of
being directly translocated by the bacteria into the host cell
cytoplasm, a feature that has been exploited to deliver Yop protein
fusions into host cells to stimulate antigen-specific CD4
+ and
CD8
+ T cells [74,75]. Additionally, T cells specific to Yops have
been isolated from Y. pseudotuberculosis-infected rats [76] or Yop-
immunized mice [77]. This indicates that Yops can be processed
into MHC I-binding peptides, and that virulence factors comprise
a subset of natural antigens. Regardless of antigenic specificity,
CTLs likely use multiple mechanisms to eliminate Yersinia. For
instance, IFNc and other CTL-secreted cytokines activate anti-
microbial function in phagocytes, allowing them to ingest nearby
bacteria [38]. T cell-secreted IFNc does contribute to protection
against Y. pestis [78] and Y. enterocolitica [34]. However, cytokine-
mediated bystander action cannot be the sole explanation for
restriction of Y. pseudotuberculosis, as cytolytic T cells (or other
perforin-expressing killer cells) are clearly involved in protection
(Figure 5). PKO mice are known to be defective for clearing
intracellular pathogens such as lymphocytic choriomeningitis virus
[79], L. monocytogenes ([80], M. tuberculosis [81] and Leishmania
amazonensis [82] but our observation that perforin-dependent
mechanisms limit Y. pseudotuberculosis is unique, given the bacteria’s
preferred extracellular locale.
We considered the possibility that CD8
+ T cells and perforin
function to restrict Yersinia in a conventional manner, that is, to
eliminate host cells harboring intracellular bacteria. Y. pseudotuber-
culosis and Y. pestis have been shown to replicate inside cultured
macrophages if the bacteria are deficient or repressed for Yop
expression [59,60]. The importance of intracellular replication for
virulence in animal hosts is unclear, and has never been
demonstrated. One expectation of this model is that the absence
of CTLs results in an increased likelihood of bacteria being found
in an intracellular locale. However, we failed to observe an
increase in intracellular bacteria in the absence of CTLs or CTL
function (Figure 6B, C), suggesting that CD8
+ T cells are not
functioning in a conventional manner to limit Yersinia replication.
On the other hand, this does not eliminate the possibility that
during the priming phase of immune responses, antigen-presenting
cells harboring intracellular bacteria stimulate Yersinia-specific
CD8
+ T cell responses. As our experiments are directed toward
asking how immunity is controlled by CD8
+ cells at times
significantly past the priming stage, we cannot rule out the
possibility that intracellular bacteria are critical for triggering
CD8
+ T cell responses in a naı ¨ve animal.
In an immune animal, another alternative model posits that
macrophages harboring intracellular bacteria are recognized and
killed by T cells in a perforin-dependent fashion, and this leads to
local inflammation that activates bystander phagocytes to clear
extracellular bacteria. Arguing against this possibility is the
observation that apoptotic cells are rapidly removed after in vivo
CTL targeting [83] to prevent the pathogenic inflammation that
results when apoptotic cells proceed to secondary necrosis [84].
Given these observations, and evidence showing that Yersinia
localizes predominantly extracellularly (Figure 6) [24–26,61], we
favor a model whereby CTLs and perforin function to protect
against extracellular Yersinia.
How would killing of host cells with attached extracellular Y.
pseudotuberculosis lead to clearance of bacteria? At least two
hypotheses exist. Firstly, perforin targeting of infected host cells
may directly eliminate bacteria, either by killing bacteria on the
host cell surface or by inducing uptake of attached bacteria. This
model is consistent with observations that perforin insertion in host
cells induces a wounded membrane response, in which lysosomes
exocytose and release lysosomal contents on the cell surface [85].
The T3SS can also induce membrane wounding, which leads to
increased uptake of Y. pseudotuberculosis lacking Yops [86]. Despite
these observations, we found no evidence that CTL targeting of
host cells with TTSS
+ surface-bound Y. pseudotuberculosis altered the
extracellular localization or viability of the bacteria, even at low
CTL-to-host cell ratios or short incubation times to lower the
effective dose of perforin (Figure 7, data not shown). A second
hypothesis is that T cell-induced cytolysis of Y. pseudotuberculosis-
associated host cells could indirectly eliminate the attached
bacteria. In this model, cytolysis marks the target cell for removal
by neighboring phagocytes, allowing cell-associated bacteria to be
phagocytosed along with the dead cell. This outcome is similar to
what is presumed to happen to the intracellular pathogen L.
monocytogenes after CTL targeting. T cell cytolysis releases the
intracellular bacteria from infected APCs, allowing bystander
phagocytes to clear released bacteria and thus prevent the bacteria
from spreading to infect nearby cells [87]. While we did not
observe that CTL targeting caused Y. pseudotuberculosis to be
released from cells (data not shown), we did observe that bacteria
associated with CTL-targeted cells were engulfed by bystander
phagocytes (Figure 8A, C) and presumably destroyed, although
limitations of the cell culture model prevented this analysis. Thus,
in this model, the propensity of Y. pseudotuberculosis to intimately
associate with host cells also renders Yersinia susceptible to
phagocytic removal after CTLs kill the bacteria-associated host
cells (Figure 8D). Other extracellular pathogens are also
restricted by CD8
+ T cells. Uropathogenic Escherichia coli (UPEC),
a causative agent of urinary tract infections (UTIs), binds tightly to
bladder epithelial cells and lives in part extracellularly [88]. It was
recently shown that in a mouse UTI model, UPEC colonization of
the bladder stimulates CD8
+ T cell responses, which contribute to
clearance of the pathogen [89], albeit by an undescribed
mechanism. It is tempting to speculate that the mechanism
described here, in which extracellularly attached bacteria are
phagocytosed as bystanders to APC elimination, may be a
common strategy to restrict this class of pathogens.
In addition to CTL killing, it is likely that other mechanisms of
host cell death restrict Yersinia replication. Interestingly, the YopJ/P
protein expressed by Yersinia can induce apoptotic death in
macrophages and dendritic cells [90–93]. YopJ/P either de-
ubiquitinates or acetylates members of the mitogen-activated
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signaling pathways, resulting in suppression of inflammatory
cytokine production and induction of cell death in infected
phagocytes [94]. Although Yersinia lacking YopJ/P are minimally
affected for virulence [95–98], recent work demonstrates that Y.
pseudotuberculosis and Y. pestis strains that hypersecrete YopJ or
express the more cytotoxic YopP variant cause more death in
cultured cells and have lowered virulence in the mouse model
[99,100]. As enhanced apoptosis is thus restrictive for Yersinia
replication, host cell death may represent an important aspect of the
anti-Yersiniaimmuneresponse.Thereis precedentforhostcell death
being protective against bacterial infection. S. typhimurium kills
phagocytes by pyroptosis, a caspase-1-dependent death mechanism
[101]. Caspase-1-deficient mice are more susceptible to S.
typhimurium colonization than are wild-type mice [102], demon-
strating that caspase-1-dependent death, or other caspase-1-
dependent functions, are required to protect hosts from Salmonella.
Furthermore, in a mouse model of Streptococcus pneumoniae lung
colonization, inhibition of macrophage apoptosis was shown to
increase bacterial burden in the lung and bloodstream, indicating
that macrophage cell death mediates bacterial clearance [103]. Our
work provides further evidence that eukaryotic cell death, in this
case induced by host functions such as perforin, may serve to limit
bacterial infection and reduce disease. The relative importance of
the combined contributions of host- and pathogen-induced cell
death upon Yersinia infection remains to be determined.
Materials and Methods
All animal use procedures were in strict accordance with the
NIH Guide for the Care and Use of Laboratory Animals and were
approved by the Tufts University Institutional Animal Care and
Use Committee.
Mouse Strains and Procedures
B6.129-B2m
tm1Jae (b2-microglobulin-deficient) and age-matched
C57BL/6 mice were obtained from Taconic Farms (Germantown,
NY), while C57BL/6-Prf1
tm1Sdz/J (perforin-deficient), B6.129S2-
Cd8a
tm1Mak/J (CD8
2/2) mice and all other C57BL/6 mice were
obtained from The Jackson Laboratory (Bar Harbor, ME).
C57BL/6-Tg(CAG-EGFP)1Osb/J (transgenic EGFP
+) mice were
a kind gift from the laboratory of Dr. Diana Bianchi, Tufts
University Medical Center. 8–10 week-old female mice were used
for all experiments and were allowed to acclimatize for 5–7 days
prior to use. Mice were housed in sterile specific-pathogen-free
conditions. For depletion studies, mice were injected intraperito-
neally with 200 mg monoclonal antibodies against murine CD8 in
200 mL phosphate-buffered saline (PBS), at days 3 and 1 prior to
infection, then days 1, 4, 7, and 10 post-infection; control mice
received PBS only [55]. Antibodies against murine CD8 (Ly-2.2,
clone 2.43, American Type Culture Collection) were purified from
hybridoma supernatants (Dr. Douglas Jefferson, Tufts University
Medical Center) and determined to be endotoxin-free (data not
shown). The CD8 deficiency status of the knockout or depleted
mice was confirmed by fluorescence-activated cell sorting (FACS)
analysis of spleen cells stained with mouse antibodies against CD8
(see Flow Cytometry below); depleted mice routinely displayed a
97–98% reduction in splenic CD8
+ T cells, while knockout mice
contained no detectable CD8
+ cells (data not shown).
Bacterial Strains
Two serotype III Y. pseudotuberculosis strain backgrounds were
used: YPIII pIB1 [43] and IP2666 [60,61]; YPIII pIB1 has a
mutation in the phoP gene, while IP2666 encodes a functional
allele [62]. YPIII pIB1
2 and IP2666c, both of which lack the
Yersinia virulence plasmid, have been described previously [61].
The ksgA
2 strain, which harbors a transposon in the kasugamycin
resistance gene [40] and the dam
OP strain, which harbors a
kanamycin resistance gene in the dam gene and a plasmid
constitutively overexpressing Escherchia coli Dam methylase [48]
were derived from YPIII pIB1. The dam
OP strain was a kind gift
from Dr. Michael Mahan, University of California Santa Barbara,
and Salmonella enterica serovar Typhimurium strain SL1344 was
kindly provided by Dr. Brad Cookson, University of Washington.
In Vivo Inoculations, Survival and Organ CFU Assays
For mouse inoculations, Y. pseudotuberculosis strains were grown
overnight in L broth at 26uC with aeration, pelleted and
resuspended in PBS to the desired concentration. Mice were
deprived of food for 18–20 hours and inoculated by oral gavage
(feeding needle no. 7920; Popper & Sons, Inc., New Hyde Park,
NY), first with 100 mL 5% sterile sodium bicarbonate, to buffer
stomach contents, then with 200 mLo f5 610
8 colony-forming
units (CFU) of ksgA
2 or YPIII pIB1 dam
OP for immunization
studies, or 5610
9 CFU of virulent YPIII pIB1 for challenge
experiments. Alternatively, mice were inoculated intravenously via
the lateral tail vein (30K gauge needle, Becton Dickinson & Co.,
Franklin Lakes NJ), with 200 mLo f1 0
2 CFU ksgA
2 or 10
3–10
4
CFU virulent YPIII pIB1, IP266 or 10
2 SL1344. For survival
experiments, animals were sacrificed upon displaying signs of
morbidity (hunched, scruffy fur, lethargy) and scored as non-
surviving. To determine CFU levels in organs, mice were
sacrificed by cervical dislocation at the indicated time points,
tissues harvested, placed in pre-weighed tubes containing sterile
PBS, and weighed to determine tissue weight. Tissues were
mechanically homogenized using a tissue homogenizer (Omni,
Marietta GA) and 100 mL of dilutions of tissue homogenate were
plated on L agar plates containing 1 mg/mL of irgasan [104]. After
48 hours incubation at room temperature, CFU were enumerated
and normalized to the gram weight of each tissue. As each animal
may have an organ weight different from the other animals,
the CFU values at or below the limit of detection (10 CFU
per mL of organ homogenate) can be different between
individual animals.
Enzyme-Linked ImmunoSorbent Assays (ELISAs)
To generate a Y. pseudotuberculosis total antigen preparation for
indirect sandwich ELISA [55], YPIII pIB1 bacteria were grown
with aeration in either high calcium medium at 26uC (Luria broth,
18–20 hours at 26uC) to inhibit Yop production or low calcium
medium at 37uC( 2 6YT broth with 20 mM sodium oxalate and
20 mM MgCl2, 1.5 hours at 26uC, 1.5 hours at 37uC) to induce
Yop production, then pelleted, resuspended in PBS and sonicated
on ice (Sonic Dismembrator, Fisher Scientific, Waltham MA)
every other 30 seconds for 5 minutes. Suspensions were cleared of
unbroken cells by low-speed centrifugation (Eppendorf, Westbury
NY), and concentration determined by bicinchoninic acid assay
(Pierce, Rockford IL). Samples prepared from bacteria grown in
high or low calcium conditions were pooled to constitute a total Y.
pseudotuberculosis antigen preparation and used to coat 96 well flat-
bottom plates (Corning Costar, Lowell MA) at a concentration of
10 mg/mL. Standards for isotype ELISAs included purified mouse
IgA, IgG1 or IgG2a (BD Biosciences Pharmingen), which were
coated on plates at 1 mg/mL. After overnight incubation of
antigen and standards at 4uC, plates were blocked with 10% fetal
calf serum, and mouse serum samples were applied in serial
dilution. Sera were prepared by centrifugation (Microtainer Serum
Separator Tube, Becton Dickinson & Co., Franklin Lakes NJ) of
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Bound antibodies were probed with alkaline phosphatase (AP)-
conjugated goat antisera against ‘‘total’’ (IgD+IgM+IgG+IgA) and
IgA, IgG1, and IgG2a isotype mouse antibodies (SouthernBiotech,
Birmingham AL), and bound AP detected with BluePhos substrate
solution (KPL, Gaithersburg MD) at an optical density (OD) of
595 nm.
Flow Cytometry
Single cell suspensions of Peyer’s patches and mesenteric lymph
nodes were prepared by gently dissociating the tissue through
70 mm nylon mesh (Falcon, BD Biosciences Discovery Labware,
San Jose CA). After removal of red blood cells by PharmLyse,
approximately 10
6 cells were stained in the presence of Fc block
(clone 2.4G2) with antibodies to murine CD4 (L3T4, clone RM4-
4, FITC conjugated), CD8 (Ly-2, clone 53-6.7, PE conjugated)
and CD69 (Very Early Activation Antigen, clone H1.2F3, PE-Cy7
conjugated). Stained cells were fixed with 2% paraformaldehyde
(Electron Microscopy Services, Hatfield PA), and data acquired on
a FACSCalibur (BD Biosciences Immunocytometry Systems, San
Diego CA). All flow cytometry reagents and antibodies were
purchased from BD Biosciences Pharmingen (San Jose CA).
Ex Vivo Gentamicin Protection Assays
Single cell suspensions of spleens from animals exposed to
bacteria were prepared by gently dissociating the tissue through
70 mm nylon mesh (Falcon, BD Biosciences Discovery Labware,
San Jose CA). The samples were assayed for gentamicin-protected
bacteria using two similar protocols. The first protocol was the
same as previously described [61]: samples were divided in two
0.5-ml aliquots: one aliquot was treated with 100 mg/ml
gentamicin while the other aliquot was left untreated. After
2 hour at 37uCi n5 %C O 2, the cells were washed three times with
PBS, lysed with 100 ml of 1% Triton-X-100 for 5 min followed by
the addition of 900 ml PBS, then lysates diluted and plated for
colon-forming units to determine the number of total and
gentamicin-protected bacteria. The second protocol is similar to
the first protocol, except aliquots for CFU determination were
removed from the same sample prior to and then after 1 hour
gentamicin treatment. The two protocols yielded comparable
results with regards to levels of % gentamicin-protected bacteria
(value equal to the number of gentamicin-protected CFU divided
by the total number of CFU multiplied by 100).
Mammalian Cell Culture
Primary cultures of bone marrow-derived macrophages were
established from femurs and tibias of C57BL/6 and EGFP
+ mice.
Bone marrow cells were grown for 6 days in high-glucose DME
medium, supplemented with 20% heat-inactivated fetal calf
serum, 10% NIH 3T3-CSF or 30% L-cell conditioned cell
supernatant, 2 mM L-glutamine, 1 mM sodium pyruvate, and
55 mM b-mercaptoethanol (Invitrogen, Carlsbad CA). Macro-
phages were cultured in 60615 mm or 150625 mm petri dishes
(Nunc LabTek Fisher Scientific, Rochester NY) prior to reseeding
in tissue culture dishes for individual assays (below). Where
indicated, macrophages were activated with 1 ng/mL recombi-
nant mouse IFNc (R&D Systems, Minneapolis MN) for 24 hours
or treated with 5 mM gliotoxin (Calbiochem, San Diego CA) for
4–6 hours. The CrpA63–71-specific T cell line was derived from
Chlamydia trachomatis-immune C57BL/6 mice (W.P. Loomis and
M. N. Starnbach, unpublished) and was maintained in RPMI
1640 medium supplemented with 10% heat-inactivated fetal calf
serum (Hyclone, Logan UT), 5% rat T-STIM with ConA (IL-2
supplement, BD Biosciences Discovery Labware, San Jose, CA),
50 mM methyl-a-D-mannopyranoside (Calbiochem, San Diego,
CA), 2 mM L-glutamine, 50 mM b-mercaptoethanol, 100 u/mL
penicillin and 100 mg/mL streptomycin (Invitrogen, Carlsbad
CA). Every 7 days, T cells were restimulated with irradiated
syngeneic splenocytes and irradiated EL4 thymoma cells stably
transfected with crpA. Non-transfected EL4 thymoma cells, used as
control antigen-presenting cells, were maintained in RPMI 1640
media supplemented exactly as for CrpA-specific CD8
+ T cells
except for the absence of IL2 supplement; 600 mg/mL geneticin
(Invitrogen, Carlsbad CA) was used for selection of EL4-crpA
transfectants.
Gentamicin Protection Assays with Bone-Marrow Derived
Macrophages
The protocol is similar to that described previously [60].
C57BL/6 bone-marrow derived macrophages (day 6 post-
harvest/derivation) were seeded onto glass coverslips (Fisherbrand,
Fisher Scientific, Waltham MA) in 24 well plates at 2610
5 per well
and allowed to adhere overnight. Bacteria were grown with
aeration in Luria broth for 18–20 hours at 26uC, and PBS-washed
samples added to macrophage-containing wells at an estimated
multiplicity of infection of 25:1. Bacteria were spun onto
macrophages at 1000 rpm, then co-cultures incubated at 37uC/
5% CO2 for 40 minutes. After washing twice in PBS, cells were
overlaid with media containing 100 mg/mL gentamicin (t=0) and
incubated for 1 hour. After washing twice in PBS, cells were
overlaid with media containing 5 mg/mL gentamicin (t=1) and
incubated further. At the indicated timepoints, cells were washed
twice with PBS and lysed with 0.2 mL 1% Triton X-100.
Following the addition of 0.8 mL PBS, samples were serially
diluted and plated to determine CFU. The % gentamicin bacteria
results from the number of gentamicin-protected CFU divided by
the total number of CFU multiplied by 100.
Cytotoxicity Assays
Bone-marrow derived macrophages were seeded to 96 well
plates at 10
4 cells per well, allowed to adhere overnight, pulsed
with or without 100 nM CrpA63–71 peptide (Biosynthesis Incor-
porated, Lewisville TX) for 1 hour, and then excess peptide was
washed away. The thymoma EL4 cells were pulsed with peptide in
suspension, then seeded similarly as macrophages. CrpA63–71-
specific CD8
+ T cells were harvested at five days post-
restimulation and added to antigen-presenting cells at the
indicated effector:target cell ratios, co-cultured for 4 hours, after
which the plates were centrifuged, supernatant removed and
assayed for the presence of the cytoplasmic enzyme lactate
dehydrogenase using the Cytotox 96 assay kit (Promega, Madison
WI) according to the manufacturers’ recommendations. %
Cytotoxicity was calculated as follows: 1006[(experimental release
– effector T cell spontaneous release – target cell spontaneous
release)/(target cell maximum release – target cell spontaneous
release)].
CTL Targeting of Yersinia-associated APCs in Culture
CTL targeting used two experimental procedures. In the first
protocol, C57BL/6 bone-marrow derived macrophages were
seeded onto glass coverslips (Fisherbrand, Fisher Scientific,
Waltham MA) in 24 well plates at 10
5 per well, allowed to adhere
overnight, and then incubated with media containing Y.
pseudotuberculosis (grown in low-calcium medium to induce Yop
expression, diluted to give a multiplicity of infection of 10:1) and
100 nM CrpA63–71 peptide. After 1 hour, macrophages were
washed three times with PBS to remove unbound bacteria and
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+ T cells (harvested at five
days post-restimulation) added at an effector:target cell ratio of 2:1.
After 15 minutes, the cells were fixed with 4% paraformaldehyde
and processed for immunofluorescence microscopy (below). In the
second protocol, GFP
+ bone marrow derived macrophages, plated
in 60615 mm Petri dishes at approximately 5610
6 cells per dish,
were challenged with Y. pseudotuberculosis at an MOI of 10:1 and
pulsed with 100 nM CrpA63–71 peptide for 1 hour, then washed
three times with PBS. Flow cytometry-sorted CrpA-specific CTLs
were added to the infected antigen-presenting cells at an
effector:target cell ratio of 2:1 and co-cultures incubated for
1 hour. All cells were then harvested and processed for
phagocytosis assays (below). Viable CTLs were sorted away from
dead irradiated feeder cells based on forward scatter and side
scatter differences (Tufts University Department of Pathology
Flow Cytometry Core) before being added to infected antigen-
presenting cells; sorted CTLs were as effective as unsorted CTLs at
targeting antigen-presenting cells for LDH release (data not
shown).
Phagocytosis Assay
C57BL/6 bone-marrow derived macrophages were seeded onto
glass coverslips (Fisherbrand, Fisher Scientific, Waltham MA) in
24 well plates at 0.5610
5 per well in medium containing 1 ng/mL
IFNc and allowed to adhere overnight. Substrate cells were then
added to IFNc-activated macrophages at a ratio of 1:1 substrate
cell:activated phagocyte and incubated together for 1–1.5 hours,
after which time the cells were fixed with 4% paraformaldehyde
and processed for immunofluorescence microscopy (below).
Coverslips with fixed stained cells were mounted with Fluoroguard
Antifade Reagent (Bio-Rad, Hercules, CA) and individual cells
inspected using a Plan-NeoFluar 1006/1.3 Ph3 objective on a
Zeiss Axioskop microscope (Carl Zeiss, Thornwood, NY) or using
a Plan-Fluor 1006/1.3 Ph3 objective on a Nikon Eclipse TE300
inverted microscope (Nikon, Tokyo, Japan). Images were captured
using a Hamamatsu Orca II camera (Hamamatsu Photonics,
Hamamatsu City, Japan). For each condition, 3 coverslips and 100
GFP
+ substrate cells per coverslip were inspected and GFP
+ cells
scored for ingestion by non-GFP IFNc-activated macrophages. %
ingestion was calculated as 1006(ingested GFP
+ cells/total GFP
+
cells).
Immunofluorescence Protection Assays of Bacterial
Uptake or Intracellular Replication
Immunofluorescence-based bacterial uptake and replication
assays were performed similarly to those described previously
[105,106]. After fixation, cells were blocked with 4% goat serum
and probed with rabbit polyclonal antibodies against Y. pseudotu-
berculosis serogroup O3 followed by goat anti-rabbit IgG
conjugated to Alexa 594 (for uptake assays) or Cascade Blue (for
intracellular replication assays) (Invitrogen Molecular Probes,
Eugene OR). The cells were then permeabilized by immersion
in ice-cold methanol for 10 seconds, blocked once more and
reprobed with anti-Y. pseudotuberculosis antibodies followed by goat
anti-rabbit IgG conjugated to Cascade Blue (for uptake assays) or
FITC (for intracellular replication assays) (Invitrogen Molecular
Probes, Eugene OR). Where indicated, for uptake assays,
macrophages were stained with rat antibodies against murine
CD11b (Integrin aM chain, clone M1/70, BD Biosciences
Pharmingen, San Jose CA) followed by goat anti-rat IgG
conjugated to FITC (Zymed, San Francisco CA). For both uptake
and intracellular replication assays, 3 coverslips and 100 infected
host cells per coverslip were inspected by fluorescence microscopy
as described above. To determine uptake, cell-associated bacteria
scored for localization and % intracellular bacteria was calculated
as 1006(intracellular bacteria/total bacteria). To determine
intracellular replication, macrophages were scored for the number
of intracellular bacteria per phagosome, and the % replicative
phagosomes calculated as 1006(phagosomes with 10+ bacteria/
total bacteria-containing phagosomes).
Data and Statistical Analysis
FlowJo (Tree Star, Ashland OR) was used to analyze flow
cytometry data. Prism (GraphPad Software, La Jolla CA) was used
for graphing and statistical analysis. To calculate the half-maximal
antibody titer of total anti-Yersinia antibodies, OD595 and log-
transformed serial dilution values were fit to a sigmoidal dose-
response curve. Survival curves were estimated using the Kaplan
Meier method and significance calculated using the log-rank test.
The nonparametric Mann-Whitney U test and unpaired Student’s
t test were used to determine statistical differences between groups
of data from animal and tissue culture experiments, respectively.
Supporting Information
Figure S1 Y. pseudotuberculosis ksgA
2 is Attenuated for Systemic
Organ Colonization Following Intravenous Delivery. C57BL/6
mice were intravenously inoculated with 2610
2 CFU of YPIII
pIB1 (virulent parental strain), yopB
2 and ksgA
2 bacteria and mice
sacrificed at day 5 post-inoculation. The number of bacteria in the
spleen (A) and liver (B) was determined by plate assay and
normalized to gram tissue weight. Each symbol indicates one
mouse and the bars indicate median values.
Found at: doi:10.1371/journal.ppat.1000573.s001 (0.51 MB PDF)
Figure S2 Y. pseudotuberculosis strain YPIII pIB1 fails to survive or
replicate inside bone-marrow-derived macrophages. C57BL/6
macrophages were challenged with the indicated strains for
1 hour, washed and treated with gentamicin, then the number
of (A) gentamicin-protected bacteria enumerated at the indicated
times post-challenge or (B) replicative phagosomes (% of
phagosomes containing 10+ bacteria as determined by immuno-
fluorescence microscopy) were enumerated at 24 hours post-
challenge. See Materials and Methods for experimental details.
Values shown represent the average of triplicate samples in a given
experiment, error bars indicate the SEM, error bars are not visible
in the growth curve results to their small size. Results are
representative of 3 experiments.
Found at: doi:10.1371/journal.ppat.1000573.s002 (0.51 MB PDF)
Figure S3 The population of CTL-targeted GFP
+ APCs
excluded from bystander phagocytosis possesses equivalent levels
of intracellular bacteria relative to non-targeted populations.
Quantification of localization of Y. pseudotuberculosis associated with
GFP
+ APCs was performed similarly as described in Figure 7
legend: bacteria associated with all GFP
+ APCs (A, duplicate of
Figure 8C for comparison) or non-engulfed GFP
+ APCs (B) were
scored for intra- and extracellular localization and the %
intracellular bacteria calculated.
Found at: doi:10.1371/journal.ppat.1000573.s003 (0.50 MB PDF)
Acknowledgments
We thank Vicki Auerbuch Stone, Philip Bergman, Elizabeth Creasey, Greg
Crimmins, Alison Davis, Alex Ensminger, Matt Heidtman, Tamara
O’Connor and Kerri-Lynn Sheahan for critical review of the manuscript
and all members of the Isberg and Mecsas laboratories for helpful
discussion. We are also grateful to three anonymous reviewers for helpful
suggestions.
Yersinia pseudotuberculosis and Cytolytic T Cells
PLoS Pathogens | www.plospathogens.org 14 September 2009 | Volume 5 | Issue 9 | e1000573Author Contributions
Conceived and designed the experiments: MAB RRI. Performed the
experiments: MAB. Analyzed the data: MAB WPL JM MNS RRI.
Contributed reagents/materials/analysis tools: WPL JM MNS RRI. Wrote
the paper: MAB RRI.
References
1. Brubaker RR (1972) The genus Yersinia: biochemistry and genetics of virulence.
Curr Top Microbiol Immunol 57: 111–158.
2. Prentice MB, Rahalison L (2007) Plague. Lancet 369: 1196–1207.
3. Naktin J, Beavis KG (1999) Yersinia enterocolitica and Yersinia pseudotuberculosis.
Clin Lab Med 19: 523–536, vi.
4. Carter PB (1975) Pathogenecity of Yersinia enterocolitica for mice. Infect Immun
11: 164–170.
5. Carter PB, Collins FM (1974) Experimental Yersinia enterocolitica infection in
mice: kinetics of growth. Infect Immun 9: 851–857.
6. Isberg RR, Leong JM (1990) Multiple beta 1 chain integrins are receptors for
invasin, a protein that promotes bacterial penetration into mammalian cells.
Cell 60: 861–871.
7. Pepe JC, Miller VL (1993) Yersinia enterocolitica invasin: a primary role in the
initiation of infection. Proc Natl Acad Sci U S A 90: 6473–6477.
8. Bliska JB, Copass MC, Falkow S (1993) The Yersinia pseudotuberculosis adhesin
YadA mediates intimate bacterial attachment to and entry into HEp-2 cells.
Infect Immun 61: 3914–3921.
9. Yang Y, Isberg RR (1993) Cellular internalization in the absence of invasin
expression is promoted by the Yersinia pseudotuberculosis yadA product. Infect
Immun 61: 3907–3913.
10. Yang Y, Merriam JJ, Mueller JP, Isberg RR (1996) The psa locus is responsible
for thermoinducible binding of Yersinia pseudotuberculosis to cultured cells. Infect
Immun 64: 2483–2489.
11. Marra A, Isberg RR (1997) Invasin-dependent and invasin-independent
pathways for translocation of Yersinia pseudotuberculosis across the Peyer’s patch
intestinal epithelium. Infect Immun 65: 3412–3421.
12. Autenrieth IB, Firsching R (1996) Penetration of M cells and destruction of
Peyer’s patches by Yersinia enterocolitica: an ultrastructural and histological study.
J Med Microbiol 44: 285–294.
13. Zhang SS, Park CG, Zhang P, Bartra SS, Plano GV, et al. (2008) The
plasminogen activator Pla of Yersinia pestis utilizes murine DEC-205 (CD205) as
a receptor to promote dissemination. J Biol Chem.
14. Kolodziejek AM, Sinclair DJ, Seo KS, Schnider DR, Deobald CF, et al. (2007)
Phenotypic characterization of OmpX, an Ail homologue of Yersinia pestis KIM.
Microbiology 153: 2941–2951.
15. Lathem WW, Price PA, Miller VL, Goldman WE (2007) A plasminogen-
activating protease specifically controls the development of primary pneumonic
plague. Science 315: 509–513.
16. Felek S, Krukonis ES (2008) The Yersinia pestis Ail protein mediates binding and
Yop-delivery to host cells required for plague virulence. Infect Immun 77(2):
825–36.
17. Cornelis GR (2002) The Yersinia Ysc-Yop ‘type III’ weaponry. Nat Rev Mol
Cell Biol 3: 742–752.
18. Viboud GI, Bliska JB (2005) Yersinia outer proteins: role in modulation of host
cell signaling responses and pathogenesis. Annu Rev Microbiol 59: 69–89.
19. Marketon MM, DePaolo RW, DeBord KL, Jabri B, Schneewind O (2005)
Plague bacteria target immune cells during infection. Science 309: 1739–1741.
20. Zink DL, Feeley JC, Wells JG, Vanderzant C, Vickery JC, et al. (1980)
Plasmid-mediated tissue invasiveness in Yersinia enterocolitica. Nature 283:
224–226.
21. Gemski P, Lazere JR, Casey T, Wohlhieter JA (1980) Presence of a virulence-
associated plasmid in Yersinia pseudotuberculosis. Infect Immun 28: 1044–1047.
22. Portnoy DA, Blank HF, Kingsbury DT, Falkow S (1983) Genetic analysis of
essential plasmid determinants of pathogenicity in Yersinia pestis. J Infect Dis
148: 297–304.
23. Bolin I, Norlander L, Wolf-Watz H (1982) Temperature-inducible outer
membrane protein of Yersinia pseudotuberculosis and Yersinia enterocolitica is
associated with the virulence plasmid. Infect Immun 37: 506–512.
24. Heesemann J, Gaede K, Autenrieth IB (1993) Experimental Yersinia enterocolitica
infection in rodents: a model for human yersiniosis. Apmis 101: 417–429.
25. Lathem WW, Crosby SD, Miller VL, Goldman WE (2005) Progression of
primary pneumonic plague: a mouse model of infection, pathology, and
bacterial transcriptional activity. Proc Natl Acad Sci U S A 102: 17786–17791.
26. Sebbane F, Gardner D, Long D, Gowen BB, Hinnebusch BJ (2005) Kinetics of
disease progression and host response in a rat model of bubonic plague.
Am J Pathol 166: 1427–1439.
27. Heesemann J, Laufs R (1985) Double immunofluorescence microscopic
technique for accurate differentiation of extracellularly and intracellularly
located bacteria in cell culture. J Clin Microbiol 22: 168–175.
28. Rosqvist R, Forsberg A, Rimpilainen M, Bergman T, Wolf-Watz H (1990) The
cytotoxic protein YopE of Yersinia obstructs the primary host defence. Mol
Microbiol 4: 657–667.
29. Grosdent N, Maridonneau-Parini I, Sory MP, Cornelis GR (2002) Role of
Yops and adhesins in resistance of Yersinia enterocolitica to phagocytosis. Infect
Immun 70: 4165–4176.
30. Janeway CA, Jr., Travers P, Walport M, Shlomchik M (2005) Immunobiology :
the immune system in health and disease. London ; San Francisco: New York:
Current Biology ; Garland Pub., 1 v. (various pagings).
31. Lawton WD, Erdman RL, Surgalla MJ (1963) Biosynthesis and Purification of
V and W Antigen in Pasteurella Pestis. J Immunol 91: 179–184.
32. Une T, Brubaker RR (1984) Roles of V antigen in promoting virulence and
immunity in Yersiniae. J Immunol 133: 2226–2230.
33. Sory MP, Boland A, Lambermont I, Cornelis GR (1995) Identification of the
YopE and YopH domains required for secretion and internalization into the
cytosol of macrophages, using the cyaA gene fusion approach. Proc Natl Acad
Sci U S A 92: 11998–12002.
34. Autenrieth IB, Tingle A, Reske-Kunz A, Heesemann J (1992) T lymphocytes
mediate protection against Yersinia enterocolitica in mice: characterization of
murine T-cell clones specific for Y. enterocolitica. Infect Immun 60: 1140–1149.
35. Parent MA, Berggren KN, Kummer LW, Wilhelm LB, Szaba FM, et al. (2005)
Cell-mediated protection against pulmonary Yersinia pestis infection. Infect
Immun 73: 7304–7310.
36. Philipovskiy AV, Smiley ST (2007) Vaccination with Live Yersinia pestis Primes
CD4 and CD8 T Cells That Synergistically Protect against Lethal Pulmonary
Y. pestis Infection. Infect Immun 75: 878–885.
37. Autenrieth IB, Beer M, Bohn E, Kaufmann SH, Heesemann J (1994) Immune
responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6
mice: an essential role for gamma interferon. Infect Immun 62: 2590–2599.
38. Nathan CF, Murray HW, Wiebe ME, Rubin BY (1983) Identification of
interferon-gamma as the lymphokine that activates human macrophage
oxidative metabolism and antimicrobial activity. J Exp Med 158: 670–689.
39. Russell JH, Ley TJ (2002) Lymphocyte-mediated cytotoxicity. Annu Rev
Immunol 20: 323–370.
40. Mecsas J, Bilis I, Falkow S (2001) Identification of attenuated Yersinia
pseudotuberculosis strains and characterization of an orogastric infection in
BALB/c mice on day 5 postinfection by signature-tagged mutagenesis. Infect
Immun 69: 2779–2787.
41. Helser TL, Davies JE, Dahlberg JE (1972) Mechanism of kasugamycin
resistance in Escherichia coli. Nat New Biol 235: 6–9.
42. O’Farrell HC, Scarsdale JN, Rife JP (2004) Crystal structure of KsgA, a
universally conserved rRNA adenine dimethyltransferase in Escherichia coli.
J Mol Biol 339: 337–353.
43. Barnes PD, Bergman MA, Mecsas J, Isberg RR (2006) Yersinia pseudotuberculosis
disseminates directly from a replicating bacterial pool in the intestine. J Exp
Med 203: 1591–1601.
44. Hakansson S, Schesser K, Persson C, Galyov EE, Rosqvist R, et al. (1996) The
YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop
effector proteins across the target cell plasma membrane and displays a contact-
dependent membrane disrupting activity. EMBO J 15: 5812–5823.
45. Goossens PL, Milon G (1992) Induction of protective CD8+ T lymphocytes by
an attenuated Listeria monocytogenes actA mutant. Int Immunol 4: 1413–1418.
46. Hoiseth SK, Stocker BA (1981) Aromatic-dependent Salmonella typhimurium are
non-virulent and effective as live vaccines. Nature 291: 238–239.
47. Sabin AB, Ramos-Alvarez M, Alvarez-Amezquita J, Pelon W, Michaels RH, et
al. (1960) Live, orally given poliovirus vaccine. Effects of rapid mass
immunization on population under conditions of massive enteric infection
with other viruses. Jama 173: 1521–1526.
48. Julio SM, Heithoff DM, Provenzano D, Klose KE, Sinsheimer RL, et al. (2001)
DNA adenine methylase is essential for viability and plays a role in the
pathogenesis of Yersinia pseudotuberculosis and Vibrio cholerae. Infect Immun 69:
7610–7615.
49. Simonet M, Falkow S (1992) Invasin expression in Yersinia pseudotuberculosis.
Infect Immun 60: 4414–4417.
50. Toellner KM, Luther SA, Sze DM, Choy RK, Taylor DR, et al. (1998) T
helper 1 (Th1) and Th2 characteristics start to develop during T cell priming
and are associated with an immediate ability to induce immunoglobulin class
switching. J Exp Med 187: 1193–1204.
51. Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH, et al. (1990) Beta 2-
microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 344:
742–746.
52. Koller BH, Marrack P, Kappler JW, Smithies O (1990) Normal development
of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science
248: 1227–1230.
53. Santos M, Schilham MW, Rademakers LH, Marx JJ, de Sousa M, et al. (1996)
Defective iron homeostasis in beta 2-microglobulin knockout mice recapitulates
hereditary hemochromatosis in man. J Exp Med 184: 1975–1985.
54. Abbott M, Galloway A, Cunningham JL (1986) Haemochromatosis presenting
with a double Yersinia infection. J Infect 13: 143–145.
55. Coligan JE, Bierer BE, Margulies DH, Shevach EM, Strober W (2005) Current
Protocols in Immunology; Coico R, ed. New York, NY: John Wiley and Sons,
Inc.
Yersinia pseudotuberculosis and Cytolytic T Cells
PLoS Pathogens | www.plospathogens.org 15 September 2009 | Volume 5 | Issue 9 | e100057356. Fung-Leung WP, Schilham MW, Rahemtulla A, Kundig TM, Vollenweider M,
et al. (1991) CD8 is needed for development of cytotoxic T cells but not helper
T cells. Cell 65: 443–449.
57. Cullen SP, Martin SJ (2008) Mechanisms of granule-dependent killing. Cell
Death Differ 15: 251–262.
58. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, et al. (1994) Fas
and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.
Science 265: 528–530.
59. Straley SC, Harmon PA (1984) Growth in mouse peritoneal macrophages of
Yersinia pestis lacking established virulence determinants. Infect Immun 45:
649–654.
60. Pujol C, Bliska JB (2003) The ability to replicate in macrophages is conserved
between Yersinia pestis and Yersinia pseudotuberculosis. Infect Immun 71:
5892–5899.
61. Balada-Llasat JM, Mecsas J (2006) Yersinia has a tropism for B and T cell zones
of lymph nodes that is independent of the type III secretion system. PLoS
Pathog 2: e86. doi:10.1371/journal.ppat.0020086.
62. Grabenstein JP, Marceau M, Pujol C, Simonet M, Bliska JB (2004) The
response regulator PhoP of Yersinia pseudotuberculosis is important for replication
in macrophages and for virulence. Infect Immun 72: 4973–4984.
63. Miller SI, Kukral AM, Mekalanos JJ (1989) A two-component regulatory
system (phoP phoQ) controls Salmonella typhimurium virulence. Proc Natl Acad
Sci U S A 86: 5054–5058.
64. Starnbach MN, Loomis WP, Ovendale P, Regan D, Hess B, et al. (2003) An
inclusion membrane protein from Chlamydia trachomatis enters the MHC class I
pathway and stimulates a CD8+ T cell response. J Immunol 171: 4742–4749.
65. Rosqvist R, Bolin I, Wolf-Watz H (1988) Inhibition of phagocytosis in Yersinia
pseudotuberculosis: a virulence plasmid-encoded ability involving the Yop2b
protein. Infect Immun 56: 2139–2143.
66. Tarleton RL, Koller BH, Latour A, Postan M (1992) Susceptibility of beta 2-
microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356:
338–340.
67. Ladel CH, Flesch IE, Arnoldi J, Kaufmann SH (1994) Studies with MHC-
deficient knock-out mice reveal impact of both MHC I- and MHC II-
dependent T cell responses on Listeria monocytogenes infection. J Immunol 153:
3116–3122.
68. Magee DM, Williams DM, Smith JG, Bleicker CA, Grubbs BG, et al. (1995)
Role of CD8 T cells in primary Chlamydia infection. Infect Immun 63: 516–521.
69. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR (1992) Major
histocompatibility complex class I-restricted T cells are required for resistance
to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A 89:
12013–12017.
70. Cogen AL, Moore TA (2008) Beta-2-microglobulin dependent bacterial
clearance and survival during murine Klebsiella pneumoniae bacteremia. Infect
Immun.
71. Schaible UE, Collins HL, Priem F, Kaufmann SH (2002) Correction of the
iron overload defect in beta-2-microglobulin knockout mice by lactoferrin
abolishes their increased susceptibility to tuberculosis. J Exp Med 196:
1507–1513.
72. Enns CA (2001) Pumping iron: the strange partnership of the hemochromatosis
protein, a class I MHC homolog, with the transferrin receptor. Traffic 2:
167–174.
73. Brutkiewicz RR, Bennink JR, Yewdell JW, Bendelac A (1995) TAP-
independent, beta 2-microglobulin-dependent surface expression of functional
mouse CD1.1. J Exp Med 182: 1913–1919.
74. Russmann H, Gerdemann U, Igwe EI, Panthel K, Heesemann J, et al. (2003)
Attenuated Yersinia pseudotuberculosis carrier vaccine for simultaneous antigen-
specific CD4 and CD8 T-cell induction. Infect Immun 71: 3463–3472.
75. Wiedig CA, Kramer U, Garbom S, Wolf-Watz H, Autenrieth IB (2005)
Induction of CD8+ T cell responses by Yersinia vaccine carrier strains. Vaccine
23: 4984–4998.
76. Falgarone G, Blanchard HS, Virecoulon F, Simonet M, Breban M (1999)
Coordinate involvement of invasin and Yop proteins in a Yersinia pseudotuber-
culosis-specific class I-restricted cytotoxic T cell-mediated response. J Immunol
162: 2875–2883.
77. Starnbach MN, Bevan MJ (1994) Cells infected with Yersinia present an epitope
to class I MHC-restricted CTL. J Immunol 153: 1603–1612.
78. Parent MA, Wilhelm LB, Kummer LW, Szaba FM, Mullarky IK, et al. (2006)
Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2,
key elements of cellular immunity, perform critical protective functions during
humoral defense against lethal pulmonary Yersinia pestis infection. Infect Immun
74: 3381–3386.
79. Kagi D, Seiler P, Pavlovic J, Ledermann B, Burki K, et al. (1995) The roles of
perforin- and Fas-dependent cytotoxicity in protection against cytopathic and
noncytopathic viruses. Eur J Immunol 25: 3256–3262.
80. Kagi D, Ledermann B, Burki K, Hengartner H, Zinkernagel RM (1994) CD8+
T cell-mediated protection against an intracellular bacterium by perforin-
dependent cytotoxicity. Eur J Immunol 24: 3068–3072.
81. Sousa AO, Mazzaccaro RJ, Russell RG, Lee FK, Turner OC, et al. (2000)
Relative contributions of distinct MHC class I-dependent cell populations in
protection to tuberculosis infection in mice. Proc Natl Acad Sci U S A 97:
4204–4208.
82. Colmenares M, Kima PE, Samoff E, Soong L, McMahon-Pratt D (2003)
Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in
vaccine-induced immunity against Leishmania amazonensis infection. Infect
Immun 71: 3172–3182.
83. Barber DL, Wherry EJ, Ahmed R (2003) Cutting edge: rapid in vivo killing by
memory CD8 T cells. J Immunol 171: 27–31.
84. Silva MT, do Vale A, dos Santos NM (2008) Secondary necrosis in
multicellular animals: an outcome of apoptosis with pathogenic implications.
Apoptosis 13: 463–482.
85. Keefe D, Shi L, Feske S, Massol R, Navarro F, et al. (2005) Perforin triggers a
plasma membrane-repair response that facilitates CTL induction of apoptosis.
Immunity 23: 249–262.
86. Roy D, Liston DR, Idone VJ, Di A, Nelson DJ, et al. (2004) A process for
controlling intracellular bacterial infections induced by membrane injury.
Science 304: 1515–1518.
87. San Mateo LR, Chua MM, Weiss SR, Shen H (2002) Perforin-mediated CTL
cytolysis counteracts direct cell-cell spread of Listeria monocytogenes. J Immunol
169: 5202–5208.
88. Mulvey MA (2002) Adhesion and entry of uropathogenic Escherichia coli. Cell
Microbiol 4: 257–271.
89. Thumbikat P, Waltenbaugh C, Schaeffer AJ, Klumpp DJ (2006) Antigen-
specific responses accelerate bacterial clearance in the bladder. J Immunol 176:
3080–3086.
90. Monack DM, Mecsas J, Ghori N, Falkow S (1997) Yersinia signals macrophages
to undergo apoptosis and YopJ is necessary for this cell death. Proc Natl Acad
Sci U S A 94: 10385–10390.
91. Ruckdeschel K, Roggenkamp A, Lafont V, Mangeat P, Heesemann J, et al.
(1997) Interaction of Yersinia enterocolitica with macrophages leads to macrophage
cell death through apoptosis. Infect Immun 65: 4813–4821.
92. Mills SD, Boland A, Sory MP, van der Smissen P, Kerbourch C, et al. (1997)
Yersinia enterocolitica induces apoptosis in macrophages by a process requiring
functional type III secretion and translocation mechanisms and involving
YopP, presumably acting as an effector protein. Proc Natl Acad Sci U S A 94:
12638–12643.
93. Erfurth SE, Grobner S, Kramer U, Gunst DS, Soldanova I, et al. (2004) Yersinia
enterocolitica induces apoptosis and inhibits surface molecule expression and
cytokine production in murine dendritic cells. Infect Immun 72: 7045–7054.
94. Bliska JB (2006) Yersinia inhibits host signaling by acetylating MAPK kinases.
ACS Chem Biol 1: 349–351.
95. Galyov EE, Hakansson S, Wolf-Watz H (1994) Characterization of the operon
encoding the YpkA Ser/Thr protein kinase and the YopJ protein of Yersinia
pseudotuberculosis. J Bacteriol 176: 4543–4548.
96. Monack DM, Mecsas J, Bouley D, Falkow S (1998) Yersinia-induced apoptosis
in vivo aids in the establishment of a systemic infection of mice. J Exp Med 188:
2127–2137.
97. Trulzsch K, Sporleder T, Igwe EI, Russmann H, Heesemann J (2004)
Contribution of the major secreted yops of Yersinia enterocolitica O:8 to
pathogenicity in the mouse infection model. Infect Immun 72: 5227–5234.
98. Lemaitre N, Sebbane F, Long D, Hinnebusch BJ (2006) Yersinia pestis YopJ
suppresses tumor necrosis factor alpha induction and contributes to apoptosis of
immune cells in the lymph node but is not required for virulence in a rat model
of bubonic plague. Infect Immun 74: 5126–5131.
99. Brodsky IE, Medzhitov R (2008) Reduced secretion of YopJ by Yersinia limits in
vivo cell death but enhances bacterial virulence. PLoS Pathog 4: e1000067.
doi:10.1371/journal.ppat.1000573.
100. Zauberman A, Tidhar A, Levy Y, Bar-Haim E, Halperin G, et al. (2009)
Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic
plague model and induces rapid protection against pneumonic plague. PLoS
ONE 4: e5938. doi:10.1371/journal.pone.0005938.
101. Fink SL, Cookson BT (2007) Pyroptosis and host cell death responses during
Salmonella infection. Cell Microbiol 9: 2562–2570.
102. Lara-Tejero M, Sutterwala FS, Ogura Y, Grant EP, Bertin J, et al. (2006) Role
of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis. J Exp
Med 203: 1407–1412.
103. Dockrell DH, Marriott HM, Prince LR, Ridger VC, Ince PG, et al. (2003)
Alveolar macrophage apoptosis contributes to pneumococcal clearance in a
resolving model of pulmonary infection. J Immunol 171: 5380–5388.
104. Logsdon LK, Mecsas J (2003) Requirement of the Yersinia pseudotuberculosis
effectors YopH and YopE in colonization and persistence in intestinal and
lymph tissues. Infect Immun 71: 4595–4607.
105. Wong KW, Isberg RR (2003) Arf6 and phosphoinositol-4-phosphate-5-kinase
activities permit bypass of the Rac1 requirement for beta1 integrin-mediated
bacterial uptake. J Exp Med 198: 603–614.
106. Dorer MS, Kirton D, Bader JS, Isberg RR (2006) RNA interference analysis of
Legionella in Drosophila cells: exploitation of early secretory apparatus
dynamics. PLoS Pathog 2: e34. doi:10.1371/journal.ppat.0020034.
Yersinia pseudotuberculosis and Cytolytic T Cells
PLoS Pathogens | www.plospathogens.org 16 September 2009 | Volume 5 | Issue 9 | e1000573